Weekly Paclitaxel and Trastuzumab in Metastatic Breast Cancer

Clinical trial NCT01423695 · COMPLETED

Trial details

NCT number: NCT01423695
Sponsor: WiSP Wissenschaftlicher Service Pharma GmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2001-02-01
Primary completion: 2009-12-01
Enrollment: 121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.